Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transplantation of Human Allogenic Cord Blood Mononuclear Stem Cells in Autism: Safety and Efficacy of the Method

NCT04710810 is registered in ClinicalTrials.gov with St. Petersburg Bekhterev Research Psychoneurological Institute as lead sponsor.

NCT NCT04710810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04710810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transplantation of Human Allogenic Cord Blood Mononuclear Stem Cells in Autism: Safety and Efficacy of the Method
Lead sponsor
St. Petersburg Bekhterev Research Psychoneurological Institute
Phase
Phase 1
Overall status
Completed
Start date
November 4, 2019
Completion date
July 31, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder